Hookipa Biotech Gmbh
Clinical trials sponsored by Hookipa Biotech Gmbh, explained in plain language.
-
Experimental vaccines tested to train immune system against HPV cancers
Disease control CompletedThis study tested two experimental vaccines called HB-201 and HB-202 designed to teach the body's immune system to recognize and attack HPV 16-positive cancer cells. The trial involved 198 patients with advanced head and neck cancers caused by HPV 16, who received the vaccines al…
Phase: PHASE1, PHASE2 • Sponsor: Hookipa Biotech GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Researchers analyze Real-World data on advanced throat cancer treatments
Knowledge-focused CompletedThis study collected real-world information from 662 patients in the US with HPV-positive throat cancer that had returned or spread. Researchers analyzed how patients responded to standard treatments like pembrolizumab or nivolumab, with or without chemotherapy. The goal was to g…
Sponsor: Hookipa Biotech GmbH • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC